Posaconazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Delayed-Release Tablets
Available Strengths: 300 mg
Reference Brands: Noxafil(US & EU)
Category: Anti-fungal
Posaconazole Tablets is available in Delayed-Release Tablets and strengths such as 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Posaconazole Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Posaconazole Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Posaconazole delayed-release tablets are approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We facilitate efficient market access for posaconazole delayed-release tablets, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Frequently Asked Questions
Related Products
Nystatin Oral Suspensions/Tablets
Strength:
Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL
Form: Tablets/Suspensions
Reference Brands: Mycostatin, Nilstat, Nystop(US)
View Details
Nystatin Topical Creams And Ointments
Strength:
100,000 units/g, 100,000–300,000 units/g
Form: Topical Creams and Ointments
Reference Brands: Mycostatin, Nilstat, Nystop(US)
View Details
Micafungin Intravenous (Iv) Powder
Strength:
50 mg, 100 mg/vial
Form: Intravenous (IV) Powder
Reference Brands: Mycamine(US & EU)
View Details
Anidulafungin Injection
Strength:
50 mg/vial
Form: Intravenous (IV) Powder
Reference Brands: Eraxis(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
